CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 119 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q3 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $740,627 | -20.6% | 33,927 | +15.7% | 0.00% | – |
| Q2 2023 | $932,337 | -7.5% | 29,328 | -29.0% | 0.00% | -100.0% |
| Q1 2023 | $1,008,112 | +7.3% | 41,333 | +38.7% | 0.00% | 0.0% |
| Q4 2022 | $939,829 | +33.5% | 29,798 | +19.7% | 0.00% | – |
| Q3 2022 | $704,000 | -17.2% | 24,899 | -22.6% | 0.00% | – |
| Q2 2022 | $850,000 | -8.0% | 32,187 | +22.0% | 0.00% | – |
| Q1 2022 | $924,000 | +0.5% | 26,381 | -6.9% | 0.00% | – |
| Q4 2021 | $919,000 | +17.7% | 28,344 | +7.1% | 0.00% | – |
| Q3 2021 | $781,000 | +35.8% | 26,469 | +17.9% | 0.00% | – |
| Q2 2021 | $575,000 | – | 22,448 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BAIN CAPITAL INVESTORS LLC | 60,632,356 | $1,912,345 | 41.46% |
| Perceptive Advisors | 6,511,727 | $205,379,869 | 5.77% |
| Finepoint Capital LP | 517,287 | $16,315 | 5.28% |
| Artal Group S.A. | 1,900,000 | $59,926 | 3.34% |
| Affinity Asset Advisors, LLC | 215,000 | $6,781,100 | 2.66% |
| Rock Springs Capital Management LP | 2,506,464 | $79,053,875 | 1.90% |
| Hood River Capital Management LLC | 923,638 | $29,131,543 | 1.06% |
| Logos Global Management LP | 260,000 | $8,200,400 | 0.96% |
| Frazier Life Sciences Management, L.P. | 393,000 | $12,395,220 | 0.77% |
| FEDERATED HERMES, INC. | 2,867,451 | $90,439,405 | 0.25% |